Journal of Medicinal Chemistry
Q1 Journal
Journal
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Drug Discovery
Q1
└
Molecular Medicine
Q1
Publisher
SJR 2025
1.726
Q1
SJR Score
H-Index
329
Citations / Doc (2yr)
6.84
Total Docs. (latest)
1,446
Total Citations (3yr)
22,173
Publication type
Journals
ISSN
00222623, 15204804
Coverage
1959-1961, 1963-2026
Journal Rank
#1,896
Subject Categories
Drug Discovery
Q1
Molecular Medicine
Q1
Subject Areas
Aims & Scope
The Journal of Medicinal Chemistry publishes studies that contribute to an understanding of the relationship between molecular structure and biological activity or mode of action.
Some specific areas that are appropriate include the following:
-Design, synthesis, and biological evaluation of novel biologically active compounds, diagnostic agents, or labeled ligands employed as pharmacological tools.
-Molecular modifications of reported series that lead to a significantly improved understanding of their structure-activity relationships (SAR).
Routine extensions of existing series that do not utilize novel chemical or biological approaches or do not add significantly to a basic understanding of the SAR of the series will normally not be accepted for publication.
-Structural biological studies (X-ray, NMR, etc.) of relevant ligands and targets with the aim of investigating molecular recognition processes in the action of biologically active compounds.
-Molecular biological studies (e.g., site-directed mutagenesis) of macromolecular targets that lead to an improved understanding of molecular recognition.
-Computational studies that provide fresh insight into the SAR of compound series that are of current general interest or analysis of other available data that subsequently advance medicinal chemistry knowledge.
-Substantially novel computational chemistry methods with demonstrated value for the identification, optimization, or target interaction analysis of bioactive molecules.
-Effect of molecular structure on the distribution, pharmacokinetics, and metabolic transformation of biologically active compounds.
This may include design, synthesis, and evaluation of novel types of prodrugs.
-Novel methodology with broad application to medicinal chemistry, but only if the methods have been tested on relevant molecules.
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Medline
Embase
Detailed Metrics
| Total Docs. (latest) | 1,446 |
| Total Docs. (3 years) | 3,082 |
| Total Refs. | 76,224 |
| Total Citations (3 years) | 22,173 |
| Citable Docs. (3 years) | 3,013 |
| Citations / Doc. (2 years) | 6.84 |
| Ref. / Doc. | 52.71 |
| % Female | 40.2% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.